These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 11159815)

  • 1. Diabetes and endothelial dysfunction: a clinical perspective.
    Calles-Escandon J; Cipolla M
    Endocr Rev; 2001 Feb; 22(1):36-52. PubMed ID: 11159815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why does diabetes mellitus increase the risk of cardiovascular disease?
    Shahab A
    Acta Med Indones; 2006; 38(1):33-41. PubMed ID: 16479030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
    Cersosimo E; DeFronzo RA
    Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction in diabetes mellitus.
    Hadi HA; Suwaidi JA
    Vasc Health Risk Manag; 2007; 3(6):853-76. PubMed ID: 18200806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term use of angiotensin-converting enzyme inhibitors to modify endothelial dysfunction: a review of clinical investigations.
    Mancini GB
    Clin Invest Med; 2000 Apr; 23(2):144-61. PubMed ID: 10852664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Endothelial function and the microcirculation in diabetes mellitus].
    Arosio E; Minuz P; Prior M
    Ann Ital Med Int; 1999; 14(2):106-13. PubMed ID: 10399372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial dysfunction: potential clinical implications.
    Tousoulis D; Koutsogiannis M; Papageorgiou N; Siasos G; Antoniades C; Tsiamis E; Stefanadis C
    Minerva Med; 2010 Aug; 101(4):271-84. PubMed ID: 21030938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel therapies targeting vascular endothelium.
    Tousoulis D; Antoniades C; Koumallos N; Marinou K; Stefanadi E; Latsios G; Stefanadis C
    Endothelium; 2006; 13(6):411-21. PubMed ID: 17169773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endothelial dysfunction and diabetes].
    Stokić E; Derić M; Radak D
    Med Pregl; 2005; 58(9-10):459-64. PubMed ID: 16526247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus.
    Hamilton SJ; Chew GT; Watts GF
    Diab Vasc Dis Res; 2007 Jun; 4(2):89-102. PubMed ID: 17654442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome.
    Hadi HA; Carr CS; Al Suwaidi J
    Vasc Health Risk Manag; 2005; 1(3):183-98. PubMed ID: 17319104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular reactivity in diabetes mellitus.
    Chaudhuri A
    Curr Diab Rep; 2002 Aug; 2(4):305-10. PubMed ID: 12643189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction in human disease.
    Drexler H; Hornig B
    J Mol Cell Cardiol; 1999 Jan; 31(1):51-60. PubMed ID: 10072715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of insulin resistance on endothelial function: possible mechanisms and clinical implications.
    Tousoulis D; Tsarpalis K; Cokkinos D; Stefanadis C
    Diabetes Obes Metab; 2008 Sep; 10(10):834-42. PubMed ID: 18034844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current perspective. Diabetic vascular disease: from endothelial dysfunction to atherosclerosis.
    Candido R; Zanetti M
    Ital Heart J; 2005 Sep; 6(9):703-20. PubMed ID: 16212072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging role of ACE inhibitors in diabetes: from theory to therapeutic management.
    Yudkin JS
    J Diabetes Complications; 1996; 10(3):129-32. PubMed ID: 8807456
    [No Abstract]   [Full Text] [Related]  

  • 17. The endothelial dysfunction in diabetes mellitus.
    Pănuş C; Moţa M; Vladu D; Vanghelie L; Răducanu CL
    Rom J Intern Med; 2003; 41(1):27-33. PubMed ID: 15529582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial dysfunction: how can one intervene at the beginning of the cardiovascular continuum?
    Schmieder RE
    J Hypertens Suppl; 2006 Apr; 24(2):S31-5. PubMed ID: 16601559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].
    Tschudi MR; Noll G; Lüscher TP
    Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endothelial dysfunction. Therapeutic and prognostic issues].
    Kelm M; Strauer BE
    Internist (Berl); 1999 Dec; 40(12):1300-7. PubMed ID: 10642917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.